Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.
| Metric | THC | FME | FRE | RHC | MPARK | SIA | Ind. Median |
|---|---|---|---|---|---|---|---|
| P/E | 10.61● | 12.00 | 16.49 | 36.90 | 13.50 | 51.46 | 20.18 |
| P/B | 3.75 | 0.86● | 1.22 | 2.00 | 1.93 | 2.70 | 1.95 |
| EV/EBITDA | 5.81● | 6.09 | 9.46 | 16.37 | 5.85 | 19.97 | 11.19 |
| P/S | 0.84 | 0.59 | 1.05 | 0.54● | 1.37 | 2.23 | 1.13 |
| Metric | THC | FME | FRE | RHC | MPARK | SIA | Ind. Median |
|---|---|---|---|---|---|---|---|
| Current Ratio | 1.36● | 1.20 | 1.27 | 0.90 | 1.19 | 0.60 | 1.26 |
| Debt/Equity | 274.4% | 83.3% | 60.2% | 347.6% | 50.0%● | 165.1% | 59.9% |
| NetDebt/EBITDA | 2.10 | 2.82 | 2.73 | 10.29 | 0.92● | 6.97 | 1.87 |
| Metric | THC | DVA | EHC | ENSG | UHS | CHE | Ind. Median |
|---|---|---|---|---|---|---|---|
| P/E | 10.61 | 20.78 | 17.70 | 27.35 | 6.41● | 25.29 | 20.18 |
| P/B | 3.75 | -21.49● | 4.27 | 4.20 | 1.30 | 7.75 | 1.95 |
| EV/EBITDA | 5.81 | 10.63 | 9.13 | 19.49 | 5.28● | 16.24 | 11.19 |
| P/S | 0.84 | 1.17 | 1.77 | 1.88 | 0.55● | 2.59 | 1.13 |
| Metric | THC | DVA | EHC | ENSG | UHS | CHE | Ind. Median |
|---|---|---|---|---|---|---|---|
| Current Ratio | 1.36 | 1.42 | 1.17 | 1.56● | 1.08 | 0.85 | 1.26 |
| Debt/Equity | 274.4% | -1,750.0%● | 110.6% | 94.9% | 68.1% | 27.9% | 59.9% |
| NetDebt/EBITDA | 2.10 | 4.62 | 1.77 | 2.77 | 1.79 | 0.53● | 1.87 |
The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.
Data on this page refreshes once per day. Price data as of Jul 6, 26. This content is for informational purposes only and is not investment advice.